Around 25,000 people die in the European Union each year from infections resistant to antibiotics. Third-generation cephalosporins are often useless against common bacteria like Escherichia coli, and fluoroquinolones are no longer the treatment of choice for gonorrhoea because resistance has become widespread. Here, you can find news stories and articles about the issue.
Two pharmacists who have been leading work on protecting against antimicrobial resistance across the NHS have been recognised in the 2020 New Year Honours list.
Pharmacy-driven allergy assessments can provide cost savings for patients with a reported penicillin allergy, a study presented at the American Society of Health System Pharmacists’ 54th Midyear Clinical Meeting has shown.
More than half of acute trusts in England failed to reduce their antibiotic use between 2017/2018 and 2018/2019, according to figures analysed by The Pharmaceutical Journal.
Patients in England contracted 165 antibiotic resistant infections per day in 2018, a Public Health England report has estimated.
When her son fell chronically ill, Arlene Brailey found the motivation to take on a role dedicated to helping patients with resistant bacterial infections find support and trustworthy information.
Incidence of sexually transmitted infections is increasing and antimicrobial resistance is adding fuel to the fire, particularly in the case of gonorrhoea. In response, researchers are working on three major strategies to help reduce its spread and maintain susceptibility to antibiotics.
Despite the rise of resistant infections, national figures show that antibiotic use continues to grow in hospitals. However, some trusts in England are stepping up their stewardship efforts and achieving significant reductions. Here, three trusts share the secrets to their success.
An overview of the 2018 guideline for management of this sexually transmitted infection in men and women.
English Pharmacy Board member Mahendra Patel on sharing the antimicrobial stewardship message across India, with students and younger pharmacists at the vanguard.
Tackling antimicrobial resistance in cancer patients at the Christie NHS Foundation Trust Subscription
Antimicrobial resistant (AMR) infections are estimated to cause 700,000 deaths each year globally, and this figure is predicted to rise to 10 million with a cumulative cost of US$100tn by 2050
Rising antimicrobial resistance (AMR) is a recognised threat to global health. There is a perception that poor prescribing practices contribute to the problem, although data confirming this are limited. Reliable data on the quality of antimicrobial prescribing in UK hospitals are not available, with hospital drug-purchasing data most often being used ...
Pharmaceutical companies won’t develop fast, cheap and effective diagnostic tools on their own — incentives are the missing piece to tackling antimicrobial resistance.